Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia
Clinical trial NCT04679350 · TERMINATED
Trial details
- NCT number
- NCT04679350
- Sponsor
- ImmuneMed, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-18
- Primary completion
- 2022-11-30
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.